In this study, we observed that MT1B expression was significantly downregulated in liver tissues of MASH patients and in HFD-induced mouse models, consistent with the analysis of the GSE167523 database using bioinformatics tools. This evidence concerns the gene MT1B and metabolic dysfunction-associated steatohepatitis.